Organizations have three basic strategic options for gaining a competitive advantage, according to Porter's Generic Strategies model. Cost leadership, differentiation, and focus are three of them.

The increasing costs and complexity of R&D in the pharmaceutical industry have necessitated the adoption of strategic ...

deep dives into generic leaders—such as Teva, Sandoz, and Viatris—and more. Download the report to learn how to leverage these top companies’ growth plans for your investing strategy.